Schroder Ventures
Schroders is a global asset manager with £343.8 billion of assets under management and offices in 27 countries.
Business Model:
Revenue: $13B
Employees: 5,001-10,000
Rankings
Industries / Tags:
Detailed Schroder Ventures Information
Geographic Data
Address: 1 London Wall Place
City: London
State: england
Zip: EC2Y 5AU
Country: GB
Financial Info
Stage:
Raised Last:
$0
Raised Total:$4B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Schroders is a global asset management company with £103.1 billion (EUR 111.3 billion / $147.7 billion) under management as at 31 March 2009. their clients include corporations, insurance companies, local and public authorities, charities, pension funds, high net worth individuals and retail investors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2003 | CellZome | Series C | 32M |
| 3/2000 | Maverix.net | Venture Round | 0 |
| 10/2005 | Lorantis | Series C | 0 |
| 7/2000 | Picis | Series C | 0 |
| 6/2002 | Confluent Surgical | Series C | 20M |
| 1/2000 | CardioFocus | Series B | 0 |
| 10/2000 | Thoughtworks | Private Equity Round | 28M |
| 7/2002 | Quick Study Radiology | Series A | 5.2M |
| 5/2003 | Quantum Dot | Series B | 1.5M |
| 7/2003 | Quick Study Radiology | Series B | 962k |
| 2/2020 | Antler | Venture Round | 25M |
| 8/2001 | Insulet | Series B | 11M |
| 8/2008 | AEA Technology | Series A | 0 |
| 9/2004 | Solexa | Series B | 0 |
| 7/2018 | Albert Technologies | Post-IPO Equity | 0 |
| 6/2004 | Rejuvenon | Series B | 37M |
| 6/2004 | Sadra Medical | Series A | 9M |
| 12/2000 | Oxagen | Venture Round | 0 |
| 8/2004 | Avera Pharmaceutical | Series C | 0 |
| 10/2004 | Quick Study Radiology | Series C | 0 |
| 5/2004 | PowderMed | Series A | 35.8M |
| 8/2003 | Rinat Neuroscience | Series B | 40M |
| 2/2006 | Insulet Corporation | Series E | 0 |
| 4/2004 | Dynogen Pharmaceuticals | Series B | 0 |
| 9/2001 | Solexa | Series A | 12M |
| 4/2004 | Archemix | Series B | 50M |
| 8/2001 | Eyetech Pharmaceuticals | Series C | 108.5M |
| 1/2005 | Medifacts International | Series A | 0 |
| 1/2002 | Achillion Pharmaceuticals | Venture Round | 41M |
| 7/2005 | Quick Study Radiology | Series C | 0 |
| 10/2001 | Aderis Pharmaceuticals | Series D | 0 |
| 9/1997 | Picis | Series A | 12M |
| 6/2003 | Eunoe | Venture Round | 40M |
| 10/2000 | Ingenium Pharmaceuticals AG | Series B | 44M |
| 11/2003 | Auxilium Pharmaceuticals | Series D | 43M |
| 2/2020 | Antler | Venture Round | 0 |
| 7/2018 | Albert Technologies | Post-IPO Equity | 0 |
| 8/2008 | AEA Technology | Series A | 0 |
| 2/2006 | Insulet Corporation | Series E | 0 |
| 10/2005 | Lorantis | Series C | 0 |
| 7/2005 | Quick Study Radiology | Series C | 0 |
| 1/2005 | Medifacts International | Series A | 0 |
| 10/2004 | Quick Study Radiology | Series C | 0 |
| 9/2004 | Solexa | Series B | 0 |
| 8/2004 | Avera Pharmaceutical | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
